Enlivex (ENLV) has released an update. Enlivex Therapeutics has commenced the next phase of its Allocetra trial, enrolling and dosing the first ...

The prevalence of osteoarthritis (OA) is rising in Canada, largely due to an ageing population and higher obesity rates.

Yuhan Corp. posted record-breaking third-quarter results, with revenue reaching 598.8 billion won and operating profit ...

At the end of the treatment phase, researchers measured changes in knee pain ... the semaglutide group lost at least 10% of ...

Most doctors will start by ordering an MRI of your knee - which might show things like arthritis or a torn meniscus ... once ...

Enlivex Therapeutics (ENLV) announced the enrollment and dosing of the first 10 patients in the randomized Phase II stage of the ...

As the number of people with osteoarthritis, sports-related knee injuries ... especially in developing countries, is ...

Ever increasing fees at private healthcare facilities are leaving patients reeling, as basic services such as temperature ...

The demand for ACL replacement procedures is driven by the need for effective treatment options that restore knee ... The dominance is attributed to the high incidence of knee injuries, particularly ...